GIST Awareness Day 2022 – Chile
Fundación GIST Chile released a special GIST Awareness Day video featuring patients telling stories about their experiences with GIST.
Fundación GIST Chile released a special GIST Awareness Day video featuring patients telling stories about their experiences with GIST.
The Life Raft Group presented an SDH Webinar: 'Updates & Stories' on July 13th, 2022 for GIST Awareness Day featuring Dr. John Glod and patient advocate Lleyton Schelesky.
The Life Raft Group partnered with Triage Cancer to present Managing Medical Bills for GIST patients and caregivers providing valuable information on how to mitigate the financial impact of a cancer diagnosis across the continuum of care.
In this webinar, Dr. Andrew Wagner and Dr. Herbert Loong summarize abstracts and presentations presented during the ASCO22 conference relevant to the GIST patient community.
The Life Raft Group partnered with Fundación GIST México to host “Effects of Nutrition and Gut Microbiome in GIST Patients” on May 4th, 2022, presented by Ms. Berenice Carbajal-López.
The National Comprehensive Cancer Network (NCCN) creates guidelines for different diseases to guide physicians in their clinical practice. In this webinar, Dr. von Mehren will educate GIST patients and caregivers about these guidelines and provide some case study examples of how guidelines fit into the rubric of patient care.
This webinar is the Life Raft Group's presentation in honor of Rare Disease Day. Rare disease day is an observance held on the last day of February to raise awareness for rare diseases and to help improve access to treatment and medical care.
NCCN’s Dr. Crystal Denlinger and Dottie Shead reviewed general principles of appropriate survivorship care and how to access and understand patient guidelines related to survivorship care.
Dr. Yoon-Koo Kang of the Asan Medical Center, Seoul, Korea, discusses the results of his team's study on the effect of L-carnitine in muscle cramps in GIST patients who are on imatinib.
In this webinar, there were case study presentations from three top sarcoma institutions that demonstrate the value of biomarker testing. A Question & Answer session followed the presentations.